Yahoo Finance

Estimated Discount To Fair Value: 36.7%

Jamieson Wellness is trading at CA$36.46, well below its estimated fair value of CA$57.58, suggesting it may be undervalued based on cash flows. Despite debt not being fully covered by operating cash flow, earnings are forecast to grow significantly at 61.8% annually over the next three years, outpacing the Canadian market's growth rate. Recent third-quarter sales increased to CA$176.16 million from last year's CA$151.51 million, with net income rising to CA$10.56 million from CA$8.22 million a year ago.

• The analysis detailed in our Jamieson Wellness growth report hints at robust future financial performance.

• Delve into the full analysis health report here for a deeper understanding of Jamieson Wellness.

NEUCA

Overview: NEUCA S.A. is involved in the wholesale distribution of pharmaceuticals in Poland, with a market capitalization of PLN3.49 billion.

Operations: The company's revenue segments include Pharmaceutical Wholesale (Including Marketing Services) at PLN11.35 billion, Clinical Studies generating PLN438.30 million, Medical Operator contributing PLN435.48 million, Insurance Business with PLN179.83 million, and Pharmaceutical Manufacturing at PLN387.67 million.

Estimated Discount To Fair Value: 39.9%

NEUCA is trading at PLN 781, significantly below its estimated fair value of PLN 1,299.75, highlighting its potential undervaluation based on cash flows. Despite a modest revenue growth forecast of 4.4% annually, earnings are expected to grow substantially at 25.6% per year over the next three years, surpassing the Polish market's growth rate. Recent third-quarter results show sales increased to PLN 3.19 billion from last year's PLN 2.97 billion, while net income decreased slightly to PLN 41.87 million from PLN 45.09 million a year ago.

• According our earnings growth report, there's an indication that NEUCA might be ready to expand.

• Dive into the specifics of NEUCA here with our thorough financial health report.

Next Steps

• Navigate through the entire inventory of 916 Undervalued Stocks Based On Cash Flows here.

• Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.

• Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include BIT:SES TSX:JWEL and WSE:NEU.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com